The New York Stock Exchange surged on Monday after news of a potential successful late-stage COVID-19 vaccine trial by pharmaceutical companies Pfizer and BioNTech
The prospect of a coronavirus vaccine boosted the NYSE market with the Dow Jones Industrial Average rising by four percent and the S&P 500 gaining a little over two percent at the opening bell.
Pfizer announced on Monday that its experimental coronavirus vaccine was more than 90 percent effective, creating hope for a COVID-19 cure after months of pandemic crisis.
The New York Stock Exchange surged on Monday after news of a potential successful late-stage COVID-19 vaccine trial by pharmaceutical companies Pfizer and BioNTech
The prospect of a coronavirus vaccine boosted the NYSE market with the Dow Jones Industrial Average rising by four percent and the S&P 500 gaining a little over two percent at the opening bell.
Pfizer announced on Monday that its experimental coronavirus vaccine was more than 90 percent effective, creating hope for a COVID-19 cure after months of pandemic crisis.
The New York Stock Exchange surged on Monday after news of a potential successful late-stage COVID-19 vaccine trial by pharmaceutical companies Pfizer and BioNTech
The prospect of a coronavirus vaccine boosted the NYSE market with the Dow Jones Industrial Average rising by four percent and the S&P 500 gaining a little over two percent at the opening bell.
Pfizer announced on Monday that its experimental coronavirus vaccine was more than 90 percent effective, creating hope for a COVID-19 cure after months of pandemic crisis.